Piñas GarcÃa, P.; Hernández MartÃnez, F.J.; Aznárez López, N.; Castillón Torre, L.; Tena Sempere, M.E.
Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study. Antioxidants 2022, 11, 116.
https://doi.org/10.3390/antiox11010116
AMA Style
Piñas GarcÃa P, Hernández MartÃnez FJ, Aznárez López N, Castillón Torre L, Tena Sempere ME.
Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study. Antioxidants. 2022; 11(1):116.
https://doi.org/10.3390/antiox11010116
Chicago/Turabian Style
Piñas GarcÃa, Purificación, Francisco Javier Hernández MartÃnez, Núria Aznárez López, Luis Castillón Torre, and Mª Eugenia Tena Sempere.
2022. "Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study" Antioxidants 11, no. 1: 116.
https://doi.org/10.3390/antiox11010116
APA Style
Piñas GarcÃa, P., Hernández MartÃnez, F. J., Aznárez López, N., Castillón Torre, L., & Tena Sempere, M. E.
(2022). Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study. Antioxidants, 11(1), 116.
https://doi.org/10.3390/antiox11010116